The best public GLP-1 ads examples come from Meta’s Ad Library and a 2025 study of 90 GLP-1 ads. In that study, a third of the copy themes described the online visit, the pattern least exposed to Meta’s rules. The GLP-1 ads that regulators flagged promised fast weight loss, used fake people, or implied a compounded drug was FDA-approved.
Facts checked on November 2, 2026. Policy checked on November 2, 2026.
What Meta’s Ad Library showed for GLP-1 ads on November 2, 2026
The Meta Ad Library is Meta’s public record of the GLP-1 ads running now, and it hides most telehealth weight-loss creative from logged-out visitors. We searched active US ads on November 2, 2026, with Meta’s default sort, while logged out.
| Keyword search | Results Meta reported | Ads on first page | Hidden behind age check | Visible |
|---|---|---|---|---|
| “glp-1 weight loss” | about 23,000 | 27 | 23 | 4 |
| “semaglutide” | about 9,000 | 16 | 13 | 3 |
What the first pages showed:
- Every telehealth and pharmacy advertiser on both pages showed the same notice: “To see this content, you need to confirm your age by logging in.” Advertisers behind that notice included Ro, Hers, Noom, TrimRx, LifeMD, Walgreens, Amazon One Medical and Amazon Pharmacy.
- The visible ads were GLP-1 companion products: a supplement for people on GLP-1 medications with the FDA supplement disclaimer, “GLP-1 Friendly” prepared meals, an electrolyte powder video in which “This doctor explains why”, a Spanish-language collagen ad, and one shampoo advertorial that appeared three times.
- Several telehealth ads near the top had been running for months. Three Ro ads on the “glp-1 weight loss” page started running in June 2026.
The age gate matches Meta’s rule that weight-loss ads “must be targeted to people at least 18 years or older.” A logged-out swipe check therefore shows a brand mostly companion products. To study competing GLP-1 telehealth creative, you need a logged-in adult account.
To repeat the check for your own GLP-1 competitors:
- Open the Meta Ad Library, set the country to United States and the ad category to All ads.
- Search a keyword (“glp-1 weight loss”, “semaglutide”, “tirzepatide”) or a competitor’s Page name.
- Keep the Active status filter, and note the “Started running on” date of each ad.
- Open “See ad details” on long-running ads, and log in with an adult account to see age-gated creative.
- Save the Library ID of every ad you reference, so you can find it again after edits.
Ad Library result counts are not campaign counts. NBC counted campaigns in 2023, so its figure in the timeline below and our 2026 counts measure different things.
Timeline of documented GLP-1 ad examples, 2023 to 2026
The public record of GLP-1 ads on Meta runs from press counts in 2023 to a peer-reviewed ad study, a multistate letter and an FDA letter. Each row below cites one source.
| Date | Event | Source |
|---|---|---|
| February 24, 2023 to February 24, 2024 | Researchers collect GLP-1 weight-loss ads from the Facebook Ad Library and Instagram paid partnerships, 1,266 ads at the start, 90 unique ads analyzed | BMC Public Health |
| June 15, 2023 | NBC News counts “more than 4,000 active ad campaigns in the U.S. mentioning semaglutide,” then about 560 a day later, “a decline of 88% from Tuesday” | NBC News |
| September 1, 2025 | The study is published with four ad themes and sample lines | BMC Public Health |
| December 17, 2025 | 35 attorneys general ask Meta to enforce its pharmaceutical and wellness ad policies and to act on AI-generated weight-loss ads | Arizona Attorney General |
| January 16, 2026 | TODAY reports more than 170 BBB complaints about ads for a weight-loss drink falsely linked to Oprah Winfrey | TODAY |
| February 20, 2026 | FDA warning letter to MEDVi cites the claim “Same active ingredient as Wegovy® and Ozempic®.” | FDA |
| July 22, 2026 | Meta updates its Health and Wellness ad standards | Meta |
| November 2, 2026 | Our Ad Library check: about 23,000 results for “glp-1 weight loss”, most telehealth creative age-gated | Meta Ad Library |
The rule changes of July 22, 2026 are compared line by line in Meta’s weight loss ads policy for GLP-1 brands.
GLP-1 ad copy patterns in a 90-ad study
The largest public set of GLP-1 ad examples is a study of 90 Facebook and Instagram ads that ran between February 2023 and February 2024. J. Rad and G. J. Melendez-Torres grouped the copy into four themes, published in BMC Public Health on September 1, 2025.
| Theme in the study | Mentions (of 142) | Sample ad line from the study | Meta rule it meets today |
|---|---|---|---|
| Health and safety | 62 | “Wegovy - Fast and safe way to lose weight.” | Drug names need Meta authorization. Speed claims meet the clickbait rule. |
| Consultation and support | 48 | “Virtual physician consultation and lab work included.” | Describes the service. The pattern least likely to hit a rule. |
| Emotional impact | 20 | “Join thousands who have found success with Mounjaro– start your transformation today!” | Drug name plus a result promise. Clickbait rule and Rx authorization. |
| Ease and affordability | 12 | “Slim down with our affordable weight loss injections!” | Prices must match checkout under Meta’s ban on “deceptive pricing.” |
The study also describes the visuals. The authors write that the ads “consistently featured positive imagery (smiling individuals, before-after comparisons).” For dietary weight-loss products “such as supplements or pills,” Meta’s current section allows ads that “illustrate people using the product or the service, and its impact of using it, and clearly indicate the time taken to achieve noticeable results.” It still bans a “Close up on specific body area by pinching fat.”
The study’s ads predate Meta’s July 22, 2026 update, so treat the right-hand column as our reading of today’s rules. Meta prescription drug ads also need LegitScript: “Meta requires online pharmacies and telehealth providers to be actively certified with LegitScript.”
GLP-1 ad lines that regulators flagged, and Meta’s response
The GLP-1 ad examples that drew regulator letters share four traits: extreme speed, fake people, life-event deadlines and implied FDA approval. The Arizona attorney general’s release of December 17, 2025 describes them for the coalition of 35.
| What regulators described | Their wording | Meta rule it collides with (our reading) |
|---|---|---|
| Extreme speed | “One ad shows an AI-generated model losing 208 pounds in three weeks.” | “promises of specific outcomes within a set timeframe without disclaimers or qualifiers” |
| Fake people | “fake AI-created law enforcement officers, nurses, and pharmacists” | “unauthorized endorsements” (Prohibited Commercial Practices) |
| Life-event deadlines | ads that “promote weight loss for milestones like the holiday season, weddings, birthdays, and vacations” | Clickbait rule when tied to a promised result |
| Body framing | “body close-ups and side-by-side comparisons” | Pinched-fat close-up ban |
| Implied approval (FDA, February 20, 2026) | “Same active ingredient as Wegovy® and Ozempic®.” | Outside Meta’s text. The FDA letter is about compounded drugs, covered in compounded GLP-1 advertising claims the FDA flags |
Scam ads add a fifth pattern that a real brand should never resemble. TODAY’s January 16, 2026 report describes deepfake videos of “celebrities and doctors” endorsing products that “either don’t exist or aren’t FDA-approved.” Rules for real and AI spokespeople are in AI-generated doctor ads in GLP-1.
Meta’s side of the record: after NBC’s 2023 inquiry, “A spokesperson for Meta attributed the drop to the company’s enforcement efforts,” NBC reported. The attorneys general’s release noted that “Meta has existing policies on pharmaceutical and health and wellness ads” and asked Meta to enforce them.
Lessons for a GLP-1 telehealth brand’s next Meta ad
Each lesson below is tied to a fact from this page. Use the table as a pre-launch check on GLP-1 creative.
| What happened | Rule or source | What to do |
|---|---|---|
| Telehealth ads were hidden behind the age check on November 2, 2026 | Meta: “at least 18 years or older” | Set every GLP-1 ad set to 18+. Study competitors while logged in. |
| Three Ro ads from June 2026 were still running near the top in November | Ad Library start dates | Read long-running ads as a weak signal of what survives review. Run time doesn’t prove performance. |
| Consultation copy was the second-largest theme (48 of 142) | BMC Public Health, 2025 | Lead with how the online visit works. |
| A “208 pounds in three weeks” ad was named by 35 attorneys general | Arizona AG, December 17, 2025 | No weight number tied to a timeframe without a qualifier. |
| “Do you have diabetes?” is Meta’s own not-allowed example | Personal Attributes policy | Describe the program, never the viewer. Meta allows “New diabetes treatment available.” |
| FDA cited “Same active ingredient as Wegovy® and Ozempic®.” | FDA, February 20, 2026 | Compounded offers: no wording that implies FDA approval. |
| Drug names in ads | Meta Drugs and Pharmaceuticals policy | Get LegitScript and Meta authorization before naming semaglutide or tirzepatide. |
When an ad is rejected anyway, the triage steps are in Facebook ad rejected for GLP-1. To hand the media buying to us, see our whitelisted Meta agency team.
What is still open about GLP-1 ads on Meta
Two questions about GLP-1 ads on Meta were open on November 2, 2026.
- The attorneys general asked Meta to “Restrict prescription drug ads in the United States to only those that are FDA-approved.” Meta’s Drugs and Pharmaceuticals page did not mention FDA approval on November 2, 2026.
- They also asked Meta to “Prohibit weight loss drug ads that use AI- generated content.” Meta’s Health and Wellness page did not name AI-generated content on the same date.
FAQ
Can you see competitors’ GLP-1 ads in the Meta Ad Library? Yes, while they are active, but Meta hides most telehealth weight-loss creative behind an age check. On November 2, 2026, 23 of 27 first-page results for “glp-1 weight loss” asked a logged-out visitor to log in.
What are the best GLP-1 ads? No public source ranks GLP-1 ads by results. The Ad Library shows when an ad started running, which tells you what has stayed live, not what converts.
Are diet ads treated differently from GLP-1 ads on Meta? Partly. Dietary products “such as supplements or pills” fall under the Health and Wellness rules: 18+ targeting and the claim bans. An ad that promotes a prescription GLP-1 also falls under the Drugs and Pharmaceuticals policy, which requires LegitScript certification for telehealth providers and Meta authorization.
Are weight loss Facebook ads with before-and-after photos allowed? Meta’s weight-loss section no longer bans side-by-side photos by name. The pinched-fat, appearance and clickbait rules still apply, as shown in Meta’s weight loss ads policy.
Changelog
- November 2, 2026: first version.
Sources
- Meta Ad Library, active US ads, keyword search 'glp-1 weight loss' (logged out, checked November 2, 2026) · accessed
- Meta Ad Library, active US ads, keyword search 'semaglutide' (logged out, checked November 2, 2026) · accessed
- Meta Transparency Center, Advertising Standards: Health and Wellness (change log Jul 22, 2026) · accessed
- Meta Transparency Center, Advertising Standards: Drugs and Pharmaceuticals · accessed
- Meta Transparency Center, Advertising Standards: Privacy Violations and Personal Attributes · accessed
- Meta Transparency Center, Advertising Standards: Prohibited Commercial Practices · accessed
- Rad J, Melendez-Torres GJ, Critical discourse analysis of social media advertisements for GLP-1 receptor agonist weight loss drugs, BMC Public Health 25:2996 (September 1, 2025) · accessed
- NBC News, David Ingram, Ozempic and Wegovy ads on Instagram and Facebook (June 15, 2023) · accessed
- Arizona Attorney General, Attorney General Mayes pushes Meta to act on misleading AI weight loss ads (December 17, 2025) · accessed
- TODAY, Scott Stump, Fake GLP-1 and weight loss ads are flooding social media (January 16, 2026) · accessed
- FDA, Warning letter to MEDVi, LLC dba MEDVi, MARCS-CMS 721455 (February 20, 2026) · accessed